Ergoteles’s Myovant Sciences Ltd. MYOV Stock Holding History

Ergoteles’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,997	Closed	-$539K	–	1977
2022 Q4	$539K	Buy	+19,997	New	+$526K	0.02%	670
2022 Q3	–	Sell	-47,300	Closed	-$588K	–	2172
2022 Q2	$588K	Buy	+47,300	New	+$522K	0.02%	769
2022 Q1	–	Sell	-25,847	Closed	-$402K	–	1747
2021 Q4	$402K	Buy	25,847 +16,674	+182%	+$318K	0.02%	730
2021 Q3	$206K	Buy	+9,173	New	+$201K	0.01%	976

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ergoteles's MYOV Position: Q1 2023 in Review

Ergoteles sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 19,997 shares — an estimated $539K sold.

Ergoteles first reported a position in MYOV in Q3 2021 and held it in 4 quarters. The position peaked at $588K in Q2 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Ergoteles reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 19,997 Myovant Sciences Ltd. shares in Q1 2023, an estimated $539K.
Ergoteles first reported a position in Myovant Sciences Ltd. in Q3 2021 and held it in 4 quarters.
Ergoteles's Myovant Sciences Ltd. position peaked at $588K in Q2 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.